REPORT ON THE RISK ASSESSMENT OF KETAMINE IN THE FRAMEWORK OF THE JOINT ACTION ON NEW SYNTHETIC DRUGS
Enregistré dans:
EUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION, REPORT ON THE RISK ASSESSMENT OF KETAMINE IN THE FRAMEWORK OF THE JOINT ACTION ON NEW SYNTHETIC DRUGS. LISBOA, EUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION, 2000, 10 p., 116 p.
Ref.
111083
Localisation:
SIIS Archivo D17.4.6 Depósito D
Palabras clave:
Anestesia, Características, Drogodependencias, Efectos, Evaluación, Riesgo
Anestesia, Características, Drogodependencias, Efectos, Evaluación, Riesgo
Documents similaires: REPORT ON THE RISK ASSESSMENT OF KETAMINE IN THE FRAMEWORK OF THE JOINT ACTION ON NEW SYNTHETIC DRUGS
- REPORT ON THE RISK ASSESSMENT OF GHB IN THE FRAMEWORK OF THE JOINT ACTION ON NEW SYNTHETIC DRUGS
- REPORT ON THE RISK ASSESSMENT OF PMMA IN THE FRAMEWORK OF THE JOINT ACTION ON NEW SYNTHETIC DRUGS
- REPORT ON THE RISK ASSESSMENT OF TMA-2 IN THE FRAMEWORK OF THE JOINT ACTION ON NEW SYNTHETIC DRUGS
- REPORT ON THE RISK ASSESSMENT OF 4-MTA IN THE FRAMEWORK OF THE JOINT ACTION ON NEW SYNTHETIC DRUGS
- REPORT ON THE RISK ASSESSMENT OF MBDB IN THE FRAMEWORK OF THE JOINT ACTION ON NEW SYNTHETIC DRUGS. GUIDELINES FOR THE RISK ASSESSMENT OF NEW SYNTHETIC DRUGS
- REPORT ON THE RISK ASSESSMENT OF 2C-I, 2C-T-2 AND 2C-T-7 IN THE FRAMEWORK OF THE JOINT ACTION ON NEW SYNTHETIC DRUGS